Michelle Morin
About Michelle Morin
Michelle Morin is the Global M&A Lead and Director of Strategic Transactions at Bristol-Myers Squibb in New York, with over 20 years of experience in the pharmaceutical and biotechnology industries.
Current Position at Bristol-Myers Squibb
Michelle Morin serves as the Global M&A Lead and Director of Strategic Transactions at Bristol-Myers Squibb. She is responsible for leading global mergers and acquisitions efforts and directing strategic transactions for the company. Michelle has held this leadership position since April 2011, continuing to make significant contributions to the company’s growth and strategic initiatives.
Previous Roles at Bristol-Myers Squibb
Michelle Morin has held various roles at Bristol-Myers Squibb, including Associate Director, Oncology Portfolio and Asset Strategy (2010-2011) and Manager, Portfolio and Asset Strategy, Oncology (2008-2010). She has been pivotal in shaping portfolio strategies and managing assets within the oncology sector. Her earlier roles provided a strong foundation for her current leadership in mergers and acquisitions.
Experience at Nexgenix Pharmaceuticals
Michelle Morin worked at Nexgenix Pharmaceuticals from 2006 to 2008 as the Director of Corporate Development. In this role, she focused on corporate development strategies and initiatives, contributing to the company’s growth and strategic direction. Her experience here added to her extensive background in the pharmaceutical sector.
Business Education at Duke University
Michelle Morin completed her Master of Business Administration (MBA) from Duke University - The Fuqua School of Business in 2013. This education provided her with advanced business knowledge and strategic management skills, complementing her robust career in the pharmaceutical and biotechnology industries.
Early Career in Investor Relations and Staffing Consultancy
In the early stages of her career, Michelle Morin worked as an Investor Relations Manager at Adherex Technologies (2002-2003) and as a Staffing Consultant at Computer Horizons (1999-2001). These roles allowed her to cultivate essential skills in investor relations and human resources, forming a well-rounded foundation for her future leadership roles.